Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB313873

CD55/DAF Antibody (278810), PE/Cy7, Novus Biologicals™
SDP

Catalog No. NB313873 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB313873 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB313873 Supplier Novus Biologicals Supplier No. FAB20091PECY7
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

CD55/DAF Monoclonal antibody specifically detects CD55/DAF in Human samples. It is validated for Flow Cytometry

Specifications

Antigen CD55/DAF
Applications Flow Cytometry
Classification Monoclonal
Clone 278810
Conjugate PE-Cyanine7
Dilution Flow Cytometry
Formulation PBS
Gene Alias CD55 antigen, CD55 molecule, decay accelerating factor for complement (Cromer blood group), CRdecay accelerating factor for complement (CD55, Cromer blood group system), CROMDAFcomplement decay-accelerating factor, decay accelerating factor for complement, TC
Host Species Mouse
Immunogen NS0-derived recombinant human CD55/DAF, Asp35-Ser353, Accession # P08174.4
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 1604
Target Species Human
Content And Storage Store at 4C in the dark. Do not freeze.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.